Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Sabarubicin

EU orphan designation number: EU/3/04/255
Active ingredient: Sabarubicin
Indication: Treatment of small cell lung cancer
Sponsor: Menarini Ricerche S.p.A.
Via Tito Speri 10, 00040 Pomezia Roma, Italia

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
24/12/2004 Centralised Orphan - Designation EMEA/OD/056/04 (2004)5560 of 21/12/2004
12/03/2009 Centralised Orphan - Removal of orphan designation from Community Register